Watch BCPC. Know when insiders buy.
One email the day a filing lands. Free.
BCPC
BALCHEM CORP
173.23
+2.45 +1.43%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
73
PASS · shorts 73
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
1 / 0
buys / sells · latest disclosed Oct 12
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $5.5BP/E 34.0DIV YIELD —FCF YIELD —REV TTM $1.1B +10.1%NET INCOME $164.4M +15.2%NET DEBT $171.9M52W 147.36 – 183.26SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $284M | +11.2% | 36.5% | $59.2M | $44.6M | +16.6% | 1.39 | $46.7M | — | — | Jul 31 |
| Q1 2026 · Mar 31 | $270.7M | +8.1% | 37.3% | $55.6M | $40.3M | +8.7% | 1.25 | $40.1M | — | — | Jul 31 |
| Q4 2025 · Dec 31 | $263.6M | +9.8% | 35.6% | $52.3M | $39.2M | +16.8% | 1.21 | $67.3M | — | — | Feb 20 |
| Q3 2025 · Sep 30 | $267.6M | +11.5% | 35.7% | $54.6M | $40.3M | +19.1% | 1.24 | $65.6M | — | — | Feb 20 |
| Q2 2025 · Jun 30 | $255.5M | +9.1% | 36.4% | $51.4M | $38.3M | +19.4% | 1.17 | $47.3M | — | — | Jul 31 |
| Q1 2025 · Mar 31 | $250.5M | +4.5% | 35.2% | $51M | $37.1M | +27.8% | 1.13 | $36.5M | — | — | Jul 31 |
| Q4 2024 · Dec 31 | $240M | +4.9% | 36.0% | $47.4M | $33.6M | +26.0% | 1.03 | $52.3M | — | — | Feb 20 |
| Q3 2024 · Sep 30 | $239.9M | +4.3% | 35.6% | $48M | $33.8M | +16.4% | 1.03 | $51.3M | — | — | Feb 20 |
| Q2 2024 · Jun 30 | $234.1M | — | 35.5% | $45.8M | $32.1M | — | 0.98 | $45M | — | — | Feb 20 |
| Q1 2024 · Mar 31 | $239.7M | — | 34.0% | $41.7M | $29M | — | 0.89 | $33.4M | — | — | Feb 20 |
| Q4 2023 · Dec 31 | $228.7M | — | 32.8% | $38.3M | $26.6M | — | 0.82 | $67.4M | — | — | Feb 20 |
| Q3 2023 · Sep 30 | $229.9M | — | 33.3% | $43.6M | $29.1M | — | 0.90 | $46.5M | $8.3M | $38.2M | Feb 21 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1B | 35.7% | $209.3M | $154.8M | 14.9% | 4.75 | $216.6M | — | — | $107.6M | $28.3M |
| FY2024 · to Dec 31 | $953.7M | 35.3% | $182.9M | $128.5M | 13.5% | 3.93 | $182M | — | — | $5.7M | $25.6M |
| FY2023 · to Dec 31 | $922.4M | 32.7% | $159.2M | $108.5M | 11.8% | 3.35 | $183.8M | — | — | $4.5M | $22.9M |
| FY2022 · to Dec 31 | $942.4M | 29.8% | $145.2M | $105.4M | 11.2% | 3.25 | $138.5M | $49.1M | $89.5M | $35.4M | $20.7M |
| FY2021 · to Dec 31 | $799M | 30.4% | $127.5M | $96.1M | 12.0% | 2.94 | $160.5M | $36.1M | $124.4M | $35.2M | $18.7M |
| FY2020 · to Dec 31 | $703.6M | 31.8% | $111.1M | $84.6M | 12.0% | 2.60 | $150.5M | $32.1M | $118.4M | $13.5M | $16.7M |
Every number comes from BALCHEM CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.